Quest Diagnostics (DGX) Other financing activities (2009 - 2026)

Quest Diagnostics has disclosed Other financing activities across 18 years of filings, most recently posting -$84.0 million for Q1 2026.

• Other financing activities for Q1 2026 came in at -$84.0 million, down 37.7% year-over-year; the trailing twelve-month figure through Mar 2026 was $16.0 million (up 33.33% YoY), and the FY2025 annual result was $39.0 million, up 85.71% from the prior year.
• Other financing activities came in at -$84.0 million for Q1 2026 at Quest Diagnostics, down from $100.0 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $100.0 million in Q4 2025 to a low of -$84.0 million in Q1 2026.
• The 5-year median for Other financing activities is $3.0 million (2024), against an average of -$2.9 million.
• Peak annual rise in Other financing activities reached 244.44% in 2023, while the deepest fall reached 866.67% in 2023.
• Quest Diagnostics' Other financing activities stood at -$20.0 million in 2022, then soared by 190.0% to $18.0 million in 2023, then jumped by 216.67% to $57.0 million in 2024, then jumped by 75.44% to $100.0 million in 2025, then sank by 184.0% to -$84.0 million in 2026.
• The last three Other financing activities figures came in at -$84.0 million (Q1 2026), $100.0 million (Q4 2025), and -$11.0 million (Q3 2025), per Business Quant data.